An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy

Combinational icaritin (IC) and coix seed oil (CSO) holds promising potential in the treatment of hepatocellular carcinoma. However, traditional cocktail therapy is facing difficulties to optimize the synergistic antitumor efficacy due to the asynchronous pharmacokinetics. Therefore, we developed an...

Full description

Bibliographic Details
Main Authors: Huating Zeng, Xiaoqi Li, Yuping Liu, Xia Li, Ding Qu, Yan Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Drug Delivery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2147601
_version_ 1828178057363456000
author Huating Zeng
Xiaoqi Li
Yuping Liu
Xia Li
Ding Qu
Yan Chen
author_facet Huating Zeng
Xiaoqi Li
Yuping Liu
Xia Li
Ding Qu
Yan Chen
author_sort Huating Zeng
collection DOAJ
description Combinational icaritin (IC) and coix seed oil (CSO) holds promising potential in the treatment of hepatocellular carcinoma. However, traditional cocktail therapy is facing difficulties to optimize the synergistic antitumor efficacy due to the asynchronous pharmacokinetics. Therefore, we developed an icaritin-loaded microemulsion based on coix seed oil (IC-MEs) for improved pharmacokinetics and enhanced antitumor efficacy. The preparation technology of IC-MEs was optimized by the Box–Behnken design and the pharmaceutical properties were characterized in detail. IC-MEs show synergistic antiproliferation against HepG2 cells compared with monotherapy. The mechanism is associated with stronger apoptosis induction via enhancing caspases-3 activity. IC-MEs significantly improve the bioavailability of IC due to the encapsulation of coix oil-based microemulsion and also obtain the desired liver accumulation and elimination. More importantly, IC-MEs exhibit the overwhelming antitumor ability among all of the treatments on the HepG2 xenograft-bearing mice. This study verifies the feasibility of using coix oil-based microemulsion to improve the antitumor effect of water-insoluble components.
first_indexed 2024-04-12T05:08:38Z
format Article
id doaj.art-bf991adb1f6942bfa1f4dc59d21529de
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-04-12T05:08:38Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-bf991adb1f6942bfa1f4dc59d21529de2022-12-22T03:46:49ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642022-12-012913454346610.1080/10717544.2022.2147601An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacyHuating Zeng0Xiaoqi Li1Yuping Liu2Xia Li3Ding Qu4Yan Chen5Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaCombinational icaritin (IC) and coix seed oil (CSO) holds promising potential in the treatment of hepatocellular carcinoma. However, traditional cocktail therapy is facing difficulties to optimize the synergistic antitumor efficacy due to the asynchronous pharmacokinetics. Therefore, we developed an icaritin-loaded microemulsion based on coix seed oil (IC-MEs) for improved pharmacokinetics and enhanced antitumor efficacy. The preparation technology of IC-MEs was optimized by the Box–Behnken design and the pharmaceutical properties were characterized in detail. IC-MEs show synergistic antiproliferation against HepG2 cells compared with monotherapy. The mechanism is associated with stronger apoptosis induction via enhancing caspases-3 activity. IC-MEs significantly improve the bioavailability of IC due to the encapsulation of coix oil-based microemulsion and also obtain the desired liver accumulation and elimination. More importantly, IC-MEs exhibit the overwhelming antitumor ability among all of the treatments on the HepG2 xenograft-bearing mice. This study verifies the feasibility of using coix oil-based microemulsion to improve the antitumor effect of water-insoluble components.https://www.tandfonline.com/doi/10.1080/10717544.2022.2147601Icaritincoix seed oil-based microemulsionhepatocellular carcinomasynergistic effectautophagy
spellingShingle Huating Zeng
Xiaoqi Li
Yuping Liu
Xia Li
Ding Qu
Yan Chen
An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
Drug Delivery
Icaritin
coix seed oil-based microemulsion
hepatocellular carcinoma
synergistic effect
autophagy
title An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
title_full An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
title_fullStr An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
title_full_unstemmed An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
title_short An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
title_sort icaritin loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy
topic Icaritin
coix seed oil-based microemulsion
hepatocellular carcinoma
synergistic effect
autophagy
url https://www.tandfonline.com/doi/10.1080/10717544.2022.2147601
work_keys_str_mv AT huatingzeng anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT xiaoqili anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT yupingliu anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT xiali anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT dingqu anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT yanchen anicaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT huatingzeng icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT xiaoqili icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT yupingliu icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT xiali icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT dingqu icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy
AT yanchen icaritinloadedmicroemulsionbasedoncoixoilforimprovedpharmacokineticsandenhancedantitumorefficacy